|

Adaptive Radiotherapy in Patients With Gynecological Tumors

RECRUITINGN/ASponsored by University Hospital, Essen
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Essen
Started2024-01-15
Est. completion2024-12-15
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06230549

Summary

Prospective randomized evaluation of adaptive radiotherapy in the definitive radiotherapy of locally advanced gynecologic carcinoma (e.g. cervical carcinoma, endometrial carcinoma, vaginal carcinoma), in the postoperative situation or first series of external beam radiotherapy and in patients in whom radical surgery or HDR brachytherapy as dose boost is not an option.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

ECOG 0-1 confirmation by histophatology MR of the pelvis staging

Exclusion Criteria:

Recurrent disease Prior Radiotherapy in pelvic region stage pM1 or cM1

Conditions9

Adaptive Radiation TherapyAdaptive RadiotherapyCancerCervical CarcinomaCurative TreatmentGynecological TumorImage Guided RadiotherapyOptimizationRadiation

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.